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Abstract Highlights
• HIV-1 RNA was isolated from long-term stored serum or plasma samples
• QIAamp Viral RNA Mini Kit and manual isolation is superior compared to other methods
• Isolated viral RNA was used for genome amplification and deep sequencing
• Storage >25 years and low viral load decreased amplification of >3kb fragments
The BEEHIVE (Bridging the Evolution and Epidemiology of HIV in Europe) project aims to analyse nearly-complete viral genomes from >3000 HIV-1 infected Europeans using highthroughput deep sequencing techniques to investigate the virus genetic contribution to virulence. Following the development of a computational pipeline, including a new de novo assembler for RNA virus genomes, to generate larger contiguous sequences (contigs) from the abundance of short sequence reads that characterise the data, another area that determines genome sequencing success is the quality and quantity of the input RNA. A pilot experiment with 125 patient plasma samples was performed to investigate the optimal method for isolation of HIV-1 viral RNA for long amplicon genome sequencing. Manual isolation with the QIAamp Viral RNA Mini Kit (Qiagen) was superior over robotically extracted RNA using either the QIAcube robotic system, the mSample Preparation Systems RNA kit with automated extraction by the m2000sp system (Abbott Molecular), or the MagNA Pure 96
System in combination with the MagNA Pure 96 Instrument (Roche Diagnostics). We scored amplification of a set of four HIV-1 amplicons of ~1.9, 3.6, 3.0 and 3.5kb, and subsequent recovery of near-complete viral genomes.
Subsequently, 616 BEEHIVE patient samples were analysed to determine factors that influence successful amplification of the genome in four overlapping amplicons using the QIAamp Viral RNA Kit for viral RNA isolation. Both low plasma viral load and high sample
Introduction
Enabled by the recent developments in high-throughput sequencing techniques, the molecular analysis of complete or nearly-complete viral genomes, including HIV, is now becoming the new research standard. Complete genomes contain more information on e.g. viral virulence elements than the shorter genome fragments that were previously investigated using Sanger dideoxynucleotide chain terminator sequencing methods. However, assembly of complete viral genomes from the relatively short reads generated by most high-throughput sequencing systems has proven to be a challenge, and much effort has been directed towards optimization of this part of the process. The computational tools to process high-throughput sequencing data are now coming of age, so that it is now time to critically examine earlier steps in the process. Many experimental steps have to be performed between the isolation of nucleic acids from a patient sample and the investigation of the assembled HIV-1 genomes. analysed. Amplification and sequencing results were compared to sample characteristics such as age and the number of viral copies used as input material for the RT reaction. In addition, an overview of nucleic acid isolation methods used in literature for HIV-1 complete genome high-throughput sequencing will be provided.
Materials and Methods

Patient material
Patients eligible for inclusion in the BEEHIVE study have to meet the following criteria: subtype B infections (Bezemer et al., 2015; van der Kuyl et al., 2013) . All HIV-1 RNA isolations for the BEEHIVE study were performed at the Department of Medical
Microbiology of the Academic Medical Center in Amsterdam, the Netherlands.
HIV-1 RNA isolation methods
Viral RNA isolation methods tested in the pilot experiments were the QIAamp Viral RNA Mini Kit that uses spin columns to purify the RNA (Qiagen, Venlo, the Netherlands), the mSample Preparation Systems RNA kit for sample preparation with automated extraction by the m2000sp system (Abbott Molecular, Des Plaines, IL, USA), and the MagNA Pure 96
System in combination with the MagNA Pure 96 Instrument (Roche Diagnostics Nederland,
Almere, Netherlands). The QIAamp Viral RNA isolation was done either manually or using the QIAcube robotic system, which is designed for fully automated sample preparation with the QIAamp RNA isolation kits. All RNA extractions were performed according to the manufacturers' instructions. For details of the isolation methods, see Supplementary Table 1 .
As input material, 200-250 µl of blood plasma or serum was used, regardless of the viral genome copy number; for the automated extractions, the input volume was 1 ml.
Quality control of the isolated HIV-1 RNA
To assess the quality of the isolated viral RNA, 10µl (1/8 ) was used in an RT-PCR using the SuperscriptIII One-step RT-PCR System with Platinum Taq DNA polymerase (Invitrogen) performed according to the manufacturer's instructions. Primers used were 5'ED31 5'-CCTCAGCCATTACACAGGCCTGTCCAAAG -3' (Delwart et al., 1995) and 3'A1191 (5'-AGCAATGTATGCCCCTCCCAT-3', position 7510-7531 of the HXB2 reference strain with GenBank accession number K03455) which target the HIV-1 envelope gene to generate a product of 725 base pairs (bp). PCR products were analysed on a 2% agarose gel. The HIV-1 envelope product could be amplified from 98.5% of the RNA samples. Samples that failed this quality control were not used for subsequent complete genome RT-PCR amplification and are not included in the numbers reported in this study.
RT-PCR amplification and high-throughput sequencing of nearly-complete HIV-1 genomes
Four 5µl aliquots of viral RNA were reverse transcribed and amplified using the SuperScriptIII One-Step RT-PCR system with Platinum Taq DNA High Fidelity polymerase (Invitrogen) using four different primer sets (Gall et al., 2012) . The pan-HIV-1 specific primer sets target semi-conserved regions of the genome and were developed using an alignment of approximately 1,500 HIV-1 genome sequences (Gall et al., 2012 FLX Titanium series reagents as described previously (Gall et al 2012) . For Illumina sequencing, 5µl of amplicon I were pooled with 10µl each of amplicons II-IV. Libraries were prepared from 50-1000ng DNA as described in Quail et al (Quail et al., 2008; Quail et al., 2012) , using one of 96 multiplex adaptors for each sample. Paired-end sequencing was performed using the Illumina MiSeq instrument as described previously (Gall et al., 2014) , with read lengths as outlined in Table 1 .
Virus genome assembly and determination of the HIV-1 subtype
Assembly of HIV-1 genomes from Roche/454 data was performed as described previously (Gall et al 2012) , while the de novo assembler IVA (Iterative Virus Assembler, (Hunt et al., 2015) ) was used for Illumina MiSeq data. A genome assembly was defined as "nearlycomplete" if (1) the contigs cover at least 96% of the amplifiable genome, demarcated by the two outermost RT-PCR primers, and (2) read coverage was present before or at the start of the gag gene and reached the end of the nef gene. Subtyping was done using COMET at the contig level (Struck et al., 2014) . Samples resulting in a single contig classified as "unassigned" by COMET, and samples resulting in multiple contigs classified as different subtypes by COMET, were categorised as "unassigned".
Overview of HIV-1 RNA isolation methods used in the literature
A survey of HIV-1 RNA isolation methods for high-throughput sequencing was performed using the PubMed database at www.ncbi.nlm.nih.gov/pubmed with the search terms HIV-1; RNA isolation; complete genome; clinical samples; next-generation sequencing, highthroughput sequencing; Illumina MiSeq; Roche 454; PacBio; Ion Torrent, in various combinations.
Results
Comparison of viral RNA isolation techniques
To investigate the optimal RNA isolation protocol for high-throughput HIV-1 sequencing, a total of 125 plasma or serum samples were processed in five pilot experiments. The number of clinical samples used in each pilot ranged from 12 to 45, and the viral loads varied from low (±12,000 copies/ml) to high (1-3×10 6 copies/ml). Three automated extraction systems with corresponding isolation kits from different suppliers were used; all reagents and machines are commercially available. In addition, manual extractions were performed with the QIAamp Viral RNA Mini Kit. The results of the pilot experiments are summarized in Table 1 . To be able to reconstruct near-complete HIV-1 genomes, it is necessary that all four RT-PCR amplicons are amplified. The number of successfully amplified amplicons from manually purified RNA isolations was greater than that from all robotically isolated RNA preparations. For RNA isolated with the m2000sp and MagNa Pure systems, more than two RT-PCR amplicons could be generated only rarely, precluding complete HIV-1 genome sequencing. The best robotic RNA isolation method used the QIAamp Viral RNA Kit in combination with the automated QIAcube system. Based on these results, it was decided to use manual extraction with the QIAamp Viral RNA Kit as the method of choice for the BEEHIVE study, notwithstanding the additional time and staff required.
Sample characteristics and HIV-1 complete genome sequencing
In five subsequent experiments, HIV-1 RNA was manually isolated, amplified by RT-PCR and sequenced from a total of 616 Dutch patient samples ( Table 1 ). The robustness of the chosen isolation method could thus be assessed, and sample characteristics associated with RT-PCR performance were investigated. Most samples (76.5%) contained subtype B viruses.
The overall RT-PCR success rate for the 616 samples, divided into five sets of 48-206 samples each, for generating the four amplicons ranged between 48 and 89% (mean 75%) (Figure 1 ). The two subsets that performed below 80% in the amplifications contained 131 samples dating to the early years of the HIV-1 epidemic in the Netherlands, i.e. from 1985-1994 ( Figure 2 ). Older samples are more likely to contain degraded viral RNA due to storage conditions or multiple freeze-thaw cycles. In favour of RNA degradation is the observation that the smallest amplicon of 1.9 kb was amplified for the majority of samples irrespective of their age, while a lower success rate was scored for the three larger amplicons (result not shown).
The initial viral load in the samples is another important factor for RT-PCR success rates, with lower viral loads expected to correlate with RT-PCR failure. Figure 3 indicates that the success rate for amplifying all four amplicons was much lower for samples with lower viral loads ≤5,000 copies/ml (34%) than for samples with high viral loads >100,000 copies/ml (86%). For samples with intermediate viral loads between 5,000 and 100,000 copies/ml, the success rate was 65%.
Viral load was, similar to sample age, not a major factor in successful amplification of the shorter,1.9 kb, amplicon, which could be amplified for 451/616 samples (73%). Individual success rates for the three larger amplicons were 65%, 62% and 64%, respectively.
HIV-1 RNA isolation methods used in other studies
A literature search for methods used to isolate HIV-1 RNA for complete genome highthroughput sequencing was performed. A total of eight publications were retrieved and inspected for the sample type involved, the RNA isolation method used and the outcomes of the sequencing protocol. The results are summarized in Table 2 . All eight studies concerned blood plasma samples, none reported the use of serum. Numbers of samples analysed ranged from one to 97. Table 2 illustrates that the studies differed greatly in the reporting of details of the samples the actual results of sequencing. Only five publications provided the viral load of the samples, or more specifically, the input RNA copy numbers for the RT-PCR amplification. Two studies reported the use of machines for RNA isolation (Luk et al., 2015; Ode et al., 2015) , one study apparently alternated between machine and manual extraction , while the remaining five studies exclusively used manual extraction Gall et al., 2012; Giallonardo et al., 2014; Henn et al., 2012; Zanini et al., 2015) . is an important factor in generating these RT-PCR amplicons, the second factor being the specific primer sets used. In earlier tests, the pan-HIV-1 primer sets employed here were used for successful amplification of HIV-1 group M, N, and O sequences, including all major group M subtypes and many circulating recombinant forms, either from cell culture reference viruses, primary clinical isolates and uncultured plasma virus samples (Gall et al., 2012) .
Therefore, we assumed that failure to amplify an HIV-1 amplicon in this pilot study is mainly due to insufficient quantity and/or quality of the isolated viral RNA, and less so due to nonmatching RT-PCR primers. We conclude that generation of the complete set of four amplicons has the highest success rate when the QIAamp Viral RNA Kit is combined with manual RNA extraction. This isolation method also worked comparatively well with machine extraction, suggesting that the QIAamp Viral RNA Kit outperforms the isolation methods from other suppliers. The outcome may suggest that manual HIV-1RNA isolation results in less shearing of the 9kb genome than robotic extractions.
Next, we used the optimal isolation method for 616 plasma samples from HIV-1-positive patients included in the BEEHIVE study to assess what sample characteristics influence the reverse transcription and/or the amplification process. We report that both sample age and plasma viral load influence the RT-PCR success. The smallest amplicon of 1.9 kb was amplified for 73.2% of the samples, whereas the larger amplicons (>3 kb) exhibit reduced success rates between 61.9 and 65.1%. The observation that amplification results correlate with amplicon length suggests that differences in the number of intact RNA copies is more important than primer mismatches with the target sequence. A low input RNA concentration in the RT-PCR reaction is most likely due a low sample viral load or because of RNA degradation related to sample age, suboptimal storage and/or multiple freeze-thaw cycles.
Analysis of the literature indicated that a wealth of RNA isolation systems are used by others.
As RT-PCR approaches differ and reporting of sequencing success was incomplete and not uniform, it is difficult to estimate the relative value of each RNA isolation method. Each study defines its own endpoint; for instance, the sequence coverage per position in the HIV-1 genome is not standardised as to what cut-off should be used for reliable assembly. Viral load is an important factor determining sequence success. However, for a number of samples with low viral loads sufficient sequence information was generated, while for some samples with high viral loads amplification steps failed, suggesting that a combination of RNA input and specific primers was more important than either of these factors alone. No study generated full-length sequences of the HIV-1 RNA genome. Due to the position of the RT-PCR primers, the complete long terminal repeats (LTR) are lacking in the study of Ode et al (Ode et al., 2015) , while in the other seven studies at least part of the LTRs are missing. The actual length of the "complete" genome thus differs between studies, although all approaches cover the entire protein-coding region. Manual extraction was done in five out of eight studies, two others reported machine isolation only, while an eighth study used a plethora of isolation methods. Manual extraction obviates the need for a machine, but it can be labour-intensive and slow when dealing with a large numbers of samples. From the present study we conclude that manual RNA isolation results in a better RNA quality necessary for complete HIV-1 genome sequencing and that shorter amplicons are more successful for sequencing directly from clinical samples.
Conclusions
Manual isolation of HIV-1 RNA from plasma with the QIAamp Viral RNA Mini Kit yields the best results when analysing the number of amplicons generated in subsequent RT-PCR reactions for complete genome high-throughput sequencing, compared with either machine RNA isolation using the same kit or other kit/machine combinations from different suppliers.
High sample age and low initial plasma viral load were found to negatively influence the amplification of HIV-1 fragments >3 kb. 
